These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36250993)

  • 1. Hypermethylation of RASSF1A gene in pediatric rhabdoid tumor of the kidney and clear cell sarcoma of the kidney.
    Ueno-Yokohata H; Okita H; Nakasato K; Kiyokawa N
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30058. PubMed ID: 36250993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methylation profile distinguishes clear cell sarcoma of the kidney from other pediatric renal tumors.
    Ueno H; Okita H; Akimoto S; Kobayashi K; Nakabayashi K; Hata K; Fujimoto J; Hata J; Fukuzawa M; Kiyokawa N
    PLoS One; 2013; 8(4):e62233. PubMed ID: 23638012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional and gene expression analysis of the p53 signaling pathway in clear cell sarcoma of the kidney and congenital mesoblastic nephroma.
    Brownlee NA; Hazen-Martin DJ; Garvin AJ; Re GG
    Pediatr Dev Pathol; 2002; 5(3):257-68. PubMed ID: 12007018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
    Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of malignant pediatric renal tumors by gene expression.
    Huang CC; Cutcliffe C; Coffin C; Sorensen PH; Beckwith JB; Perlman EJ;
    Pediatr Blood Cancer; 2006 Jun; 46(7):728-38. PubMed ID: 16425275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent methylation of RASSF1A in synovial sarcoma and the anti-tumor effects of 5-aza-2'-deoxycytidine against synovial sarcoma cell lines.
    Numoto K; Yoshida A; Sugihara S; Kunisada T; Morimoto Y; Yoneda Y; Fujita Y; Nishida K; Ouchida M; Ozaki T
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):17-25. PubMed ID: 19578875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Renal Tumors: Updates in the Molecular Era.
    Treece AL
    Surg Pathol Clin; 2020 Dec; 13(4):695-718. PubMed ID: 33183728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of demethylation and re-expression of RASSF1A gene in gastric cancer cell lines by combined treatment of 5-Aza-CdR and NaB.
    Shen WJ; Dai DQ; Teng Y; Liu HB
    World J Gastroenterol; 2008 Jan; 14(4):595-600. PubMed ID: 18203293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the RASSF1A tumor suppressor gene in Japanese clear cell renal cell carcinoma.
    Tokinaga K; Okuda H; Nomura A; Ashida S; Furihata M; Shuin T
    Oncol Rep; 2004 Oct; 12(4):805-10. PubMed ID: 15375503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-expression of RASSF1A by 5-Aza-CdR induced demethylation of the promoter region in human biliary tract carcinoma cells.
    Zuo S; Chen Y; Xu L; Tang Q; Zou S
    J Huazhong Univ Sci Technolog Med Sci; 2007 Jun; 27(3):281-4. PubMed ID: 17641842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
    Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
    Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis.
    Dreijerink K; Braga E; Kuzmin I; Geil L; Duh FM; Angeloni D; Zbar B; Lerman MI; Stanbridge EJ; Minna JD; Protopopov A; Li J; Kashuba V; Klein G; Zabarovsky ER
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7504-9. PubMed ID: 11390984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Role of 5-Aza-CdR on Methylation of Promoter in RASSF1A Gene in Endometrial Carcinoma].
    Huang LP; Chen C; Wang XP; Liu H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2015 May; 46(3):380-3. PubMed ID: 26121857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond Wilms tumor: imaging findings and outcomes of rare renal tumors in children.
    Ayaz E; Ozcan HN; Oguz B; Haliloglu M
    Pediatr Radiol; 2022 Dec; 52(13):2557-2567. PubMed ID: 35760918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of RASSF1A expression and promoter demethylation in Hep-2 cell line].
    Yang J; Ji W; Qu Y; He L; Zhao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jan; 25(2):64-6. PubMed ID: 21473137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cyclin D1 and BCOR Immunohistochemistry in Differentiating Clear Cell Sarcoma of Kidney From its Mimics.
    Singh V; Gupta K; Saraswati A; Peters NJ; Trehan A
    J Pediatr Hematol Oncol; 2021 Nov; 43(8):294-300. PubMed ID: 34673711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.
    Mühlisch J; Schwering A; Grotzer M; Vince GH; Roggendorf W; Hagemann C; Sörensen N; Rickert CH; Osada N; Jürgens H; Frühwald MC
    Oncogene; 2006 Feb; 25(7):1111-7. PubMed ID: 16186793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney.
    Mirkovic J; Calicchio M; Fletcher CD; Perez-Atayde AR
    Histopathology; 2015 Sep; 67(3):306-12. PubMed ID: 25556515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Wilms' renal tumors in children: experience with 139 cases treated at a single center.
    Fang YW; Song HC; Sun N; Zhang WP
    BMC Urol; 2022 Jun; 22(1):89. PubMed ID: 35733141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic inactivation of RASSF1A in head and neck cancer.
    Dong SM; Sun DI; Benoit NE; Kuzmin I; Lerman MI; Sidransky D
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3635-40. PubMed ID: 14506151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.